Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Harvard Bioscience Inc Announces Retirement Of CEO And Appointment Of Interim CEO

Wednesday, 15 May 2013 07:30am EDT 

Harvard Bioscience Inc announced that its Board of Directors has appointed David Green, the Company's President and as interim Chief Executive Officer (CEO) following the retirement and resignation of Chane Graziano as CEO and a Director of the Company. The Board of Directors will immediately commence a search to hire a new CEO . 

Company Quote

17 Dec 2014